Study Details
A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men with OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH)
Clinicaltrials.gov ID
Astellas Study ID
178-MA-1008
EudraCT ID
2015-004036-36
Condition
Enlarged Prostate, Overactive Bladder Disease
Phase
Phase 4
Age
40 years - N/A
Sex
Male
Product
N/A
Type
Interventional
Trial Dates
Jun 2016 - Sep 2018
Masking
Double (Participant, Investigator)
Enrollment number
715
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men with Overactive Bladder (OAB) Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH)
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men with OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH)? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site ES34004
Vigo, Spain, 36211
Site US01053
Hialeah, United States, 33016
Site GB44005
Bristol, United Kingdom, BS10 5NB
Site CA15005
Toronto, Canada, M4N 3M5
Site GB44011
Bristol, United Kingdom, BS48 3HA
Site CZ42003
Praha 4, Czech Republic, 140 00
Site US01084
Melrose Park, United States, 60160
Site DE49004
Hamburg, Germany, D-22303
Site ES34003
Miranda de Ebro, Spain, 09200
Site US01067
Billings, United States, 59102
Site US01048
Las Vegas, United States, 89106
Site US01013
Burien, United States, 98166
Site US01056
Knoxville, United States, 37909
Site US01020
Brooklyn, United States, 11215
Site FR33004
Colmar Cedex, France, 68024
Site CA15004
Toronto, Canada, M6A 3B5
Site CA15008
Calgary, Canada, T2V 1P9
Site US01075
Knoxville, United States, 37912
Site GB44003
Cambridge, United Kingdom, CB2 2QQ
Site ES34001
Madrid, Spain, 28031
Site US01051
Hanover, United States, 21076
Site US01035
Springfield, United States, 62769
Site US01066
Albuquerque, United States, 87102
Site US01052
Tucson, United States, 85715
Site PL48004
Warszawa, Poland, 02-797
Site US01057
Las Vegas, United States, 89144
Site US01063
Newport News, United States, 23606
Site US01054
Greenwood, United States, 46143
Site US01019
Plainview, United States, 11803
Site US01082
Atlanta, United States, 30312
Site US01071
Mount Pleasant, United States, 29464
Site US01058
Redwood City, United States, 94062
Site US01033
Milwaukee, United States, 29425
Site US01078
Knoxville, United States, 37938
Site US01036
Los Angeles, United States, 90048
Site CA15009
Sherbrooke, Canada, J1L 0H8
Site IT39006
Pisa, Italy, 56124
Site US01007
Middleburg Heights, United States, 44130
Site US01042
Clarksville, United States, 37043
Site CZ42004
Benesov, Czech Republic, 256 01
Site DE49003
Lutherstadt Eisleben, Germany, 06295
Site US01095
San Antonio, United States, 78229
Site PL48005
Wrocław, Poland, 53-114
Site FR33003
Rouen, France, 76031
Site IT39010
Chieti, Italy, 66013
Site US01022
Augusta, United States, 30912
Site US01002
Denver, United States, 80211
Site US01028
Los Angeles, United States, 90027
Site ES34002
Sevilla, Spain, 41014
Site CA15003
Barrie, Canada, L4M 7G1
Site IT39008
Vasto, Italy, 66054
Site US01064
Valley Village, United States, 91607
Site DE49001
Hagenow, Germany, 19230
Site US01045
Sugar Land, United States, 77478
Site ES34006
Valencia, Spain, 46014
Site IT39003
Catanzaro, Italy, 88100
Site US01027
Wellington, United States, 33449
Site US01092
Cleveland, United States, 44122
Site US01096
West Jordan, United States, 84088
Site IT39005
Latina, Italy, 04100
Site GB44004
Newcastle upon Tyne, United Kingdom, NE7 7DN
Site PL48007
Wroclaw, Poland, 53-329
Site US01032
Voorhees, United States, 08053
Site US01012
Anchorage, United States, 99503
Site US01014
Poughkeepsie, United States, 12601
Site DE49006
Halle (Saale), Germany, 06132
Site CZ42005
Prague 10, Czech Republic, 101 00
Site US01083
Tucson, United States, 85710
Site GB44002
Reading, United Kingdom, RG1 5AN
Site ES34005
Orense, Spain, 32005
Site PL48001
Piaseczno, Poland, 05-500
Site US01093
Troy, United States, 48084
Site US01029
Edison, United States, 08837
Site CA15014
Victoriaville, Canada, G6P 6P6
Site US01068
San Diego, United States, 92120
Site US01088
San Jose, United States, 95124
Site US01070
Hawaiian Gardens, United States, 90712
Site CA15002
Sherbrooke, Canada, J1H 5N4
Site CA15006
Montreal, Canada, H3T 1E2
Site US01041
Baltimore, United States, 21287
Site DE49005
Hettstedt, Germany, 06333
Site US01073
Charlotte, United States, 28277
Site US01059
Santa Maria, United States, 93454
Site IT39001
Treviglio, Italy, 24047
Site US01087
Bala Cynwyd, United States, 19004
Site US01015
Garden City, United States, 11530
Site CA15012
Abbotsford, Canada, V2S3N6
Site FR33007
Valence, France, 26953 Cedex 9
Site IT39002
Avellino, Italy, 83100
Site US01044
Goodyear, United States, 85395
Site IT39004
Florence, Italy, 50139
Site ES34007
Barcelona, Spain, 08003
Site FR33001
Bordeaux, France, 33076
Site US01034
West Des Moines, United States, 50266
Site US01010
Wichita, United States, 67208
Site FR33002
Pierre Benite Cedex, France, 69495
Site US01072
Bristol, United States, 37620
Site US01026
Pompano Beach, United States, 33060
Site US01021
Murrieta, United States, 92562
Site US01005
Huntsville, United States, 35749
Site US01055
New Orleans, United States, 70121
Site US01009
Homewood, United States, 35209
Site DE49002
Duisburg, Germany, 47051
Site DE49007
Sangerhausen, Germany, 06526
Site US01069
Cary, United States, 25711
Site CA15011
Quebec City, Canada, G1N 4V3
Site US01079
Maiden, United States, 28650
Site FR33006
Lille, France, 59037
Site US01017
Greenbelt, United States, 20770
Site GB44007
Middlesborough, United Kingdom, TS4 3BW
Site CZ42006
Domazlice, Czech Republic, 339 01
Site IT39007
Rome, Italy, 00189
Site US01077
Charlotte, United States, 28209
Site US01046
Indianapolis, United States, 46202
Site US01080
Salisbury, United States, 28144
Site CA15013
Burlington, Canada, L7N 3V2
Site US01060
Kansas City, United States, 64116
Site US01097
Englewood, United States, 80113
Site US01025
Saint Petersburg, United States, 33710
Site US01031
Albuquerque, United States, 87109
Site GB44001
Sheffield, United Kingdom, S10 2JF
Site US01004
Denver, United States, 80220
Site PL48006
Katowice, Poland, 40-611
Site US01076
Raleigh, United States, 27609
Site FR33008
Limoges, France, 87042
Site CA15007
Granby, Canada, J2G 8Z9
Site US01050
Dallas, United States, 75390
Site GB44006
York, United Kingdom, YO31 8HE
Site US01039
Greensboro, United States, 27403
Site CZ42001
Sternberk, Czech Republic, 78501
Site US01008
New York, United States, 10016
Site US01094
Shreveport, United States, 71106
Site US01006
Jeffersonville, United States, 47130
Site CA15001
Brampton, Canada, L6T 4S5
Site US01018
New York, United States, 10065
Site US01047
Long Beach, United States, 90806
Site FR33005
Paris Cedex 10, France, 75020
Site US01003
Watertown, United States, 02472
Site US01061
Omaha, United States, 68114
Site US01081
Los Angeles, United States, 90035
Site US01065
Raleigh, United States, 27612
Site ES34009
Lugo, Spain, 27003
Site US01098
Lancaster, United States, 17604
Site US01016
Boston, United States, 02131
Site US01001
Concord, United States, 28025
The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website
© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
POWERED BY:
